Table 1.

Average spectral power in low-, mid-, and high-frequency bands for MAP, HR, coherence, and gain in Lv-PRSx8-AT_1A and Lv-PRSx8-GFP RVLM-microinjected mice assessed during the inactive period

	Week 0 Lv-PRSx8-GFP	Week 0 Lv-PRSx8-AT_1AR	Day 33 Lv-PRSx8-GFP	Day 33 Lv-PRSx8-AT_1AR	Week 0 Lv-PRSx8-GFP vs Lv-PRSx8-AT_1AR	Day 33 Lv-PRSx8-GFP vs Lv-PRSx8-AT_1AR	Week 0 vs Day 33 Lv-PRSx8-GFP	Week 0 vs Day 33 Lv-PRSx8-AT_1AR
Coherence
Low frequency	0.51 ± 0.03	0.43 ± 0.02	0.52 ± 0.03	0.50 ± 0.03	ns	ns	ns	ns
Midfrequency	0.63 ± 0.02	0.60 ± 0.01	0.63 ± 0.02	0.63 ± 0.02	ns	ns	ns	ns
High frequency	0.46 ± 0.03	0.44 ± 0.02	0.46 ± 0.02	0.47 ± 0.04	ns	ns	ns	ns
Gain (bpm/mmHg)
Low frequency	12.1 ± 1.0	9.8 ± 1.0	13.2 ± 1.3	12.7 ± 1.7	ns	ns	ns	ns
Midfrequency	19.8 ± 1.3	16.5 ± 1.4	19.7 ± 1.6	18.5 ± 1.6	ns	ns	ns	ns
High frequency	28.6 ± 2.0	24.3 ± 2.0	25.8 ± 2.8	19.8 ± 0.9	ns	ns	ns	ns
MAP (mmHg²)
Low frequency	0.65 ± 0.13	0.66 ± 0.16	0.95 ± 0.14	0.58 ± 0.07	ns	ns	ns	ns
Midfrequency	0.14 ± 0.03	0.23 ± 0.09	0.25 ± 0.05	0.12 ± 0.01	ns	ns	ns	ns
High frequency	0.62 ± 0.13	0.63 ± 0.09	0.90 ± 0.18	0.59 ± 0.08	ns	ns	ns	ns
Total	3.03 ± 0.58	2.82 ± 0.46	4.01 ± 0.46	2.39 ± 0.24	ns	ns	ns	ns
HR (bpm)²
Low frequency	116 ± 32	106 ± 15	226 ± 39	149 ± 32	ns	ns	ns	ns
Midfrequency	64.9 ± 17	53.7 ± 7.3	102 ± 14	63.9 ± 11	ns	ns	ns	ns
High frequency	719 ± 119	732 ± 121	894 ± 109	541 ± 63	ns	ns	ns	ns
Total	105 ± 184	1184 ± 176	1538 ± 158	926 ± 126	ns	^*	ns	ns

Data are presented as mean ± SEM, indicating between-animal variance. Low frequency, 0.08–0.3 Hz; midfrequency, 0.3–0.5 Hz; high frequency, 0.5–1 Hz; total, 0–1 Hz. ns, Not significant.
↵*p < 0.05.